Ethnic differences in primary angle-closure glaucoma.

PURPOSE OF REVIEW Observational studies from different countries have shown that populations of East Asian origin have a higher frequency of primary angle-closure glaucoma compared with those of European or African descent. As half of all cases of glaucoma reside in Asia, and with primary angle-closure glaucoma carrying a higher rate of visual morbidity, primary angle-closure glaucoma poses an important public health problem; however, the inconsistent use of techniques and definitions to detect and diagnose primary angle-closure glaucoma has resulted in difficulties in interpreting the accuracy and comparability of such data. Therefore it is important to review these studies in the light of a consistent classification system. RECENT FINDINGS There are increasing reports that support previous findings on the incidence and prevalence of primary angle-closure glaucoma in different ethnic groups. There have also been further investigations into the mechanism and natural history of primary angle-closure glaucoma in Asian populations. SUMMARY International investigations into primary angle-closure glaucoma have demonstrated reproducible evidence that ethnic variations do exist. Cross-sectional studies in this area have also suggested that differences in anterior chamber depth, together with its association with peripheral anterior synechiae, may be part of the underlying mechanism behind these differences. The ideas generated need to be further explored with longitudinal data of changes in anterior chamber depth and peripheral anterior synechiae in different populations. The detailed mechanisms behind the development of angle-closure and primary angle-closure glaucoma should also be investigated.

[1]  I. Lerman Adherence to treatment: the key for avoiding long-term complications of diabetes. , 2005, Archives of medical research.

[2]  H. Taylor,et al.  The prevalence of glaucoma among Eskimos of northwest Alaska. , 1987, Archives of ophthalmology.

[3]  M. Kass,et al.  Compliance with topical pilocarpine treatment. , 1986, American journal of ophthalmology.

[4]  Y. Frishberg,et al.  Is Noncompliance Among Adolescent Renal Transplant Recipients Inevitable? , 2005, Pediatrics.

[5]  M. Kass,et al.  Compliance with topical timolol treatment. , 1987, American journal of ophthalmology.

[6]  R K John,et al.  Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study. , 2000, Ophthalmology.

[7]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[8]  A. Rotchford,et al.  Temba glaucoma study: a population-based cross-sectional survey in urban South Africa. , 2003, Ophthalmology.

[9]  Y. Yassur,et al.  Epidemiology of acute angle-closure glaucoma: incidence and seasonal variations. , 1985, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[10]  A. Reidy,et al.  Prevalence of glaucoma in the west of Ireland. , 1993, The British journal of ophthalmology.

[11]  Alsbirk Ph Anatomical risk factors in primary angle-closure glaucoma. A ten year follow up survey based on limbal and axial anterior chamber depths in a high risk population. , 1992 .

[12]  P. Alsbirk ANTERIOR CHAMBER DEPTH IN GREENLAND ESKIMOS , 1974, Acta ophthalmologica.

[13]  D. Friedman,et al.  Ultrasonographic biomicroscopy, Scheimpflug photography, and novel provocative tests in contralateral eyes of Chinese patients initially seen with acute angle closure. , 2003, Archives of ophthalmology.

[14]  N. Pfeiffer,et al.  Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[15]  R. Pandey,et al.  Ocular parameters in the subgroups of angle closure glaucoma , 2000, Clinical & experimental ophthalmology.

[16]  P. Foster,et al.  Can we prevent angle-closure glaucoma? , 2005, Eye.

[17]  P. Foster,et al.  Rates of hospital admissions for primary angle closure glaucoma among Chinese, Malays, and Indians in Singapore , 2000, The British journal of ophthalmology.

[18]  M. Luntz Primary angle-closure glaucoma in urbanized South African caucasoid and negroid communities. , 1973, The British journal of ophthalmology.

[19]  E. MacLaughlin,et al.  Assessing Medication Adherence in the Elderly , 2005, Drugs & aging.

[20]  R. Parikh,et al.  Five year risk of progression of primary angle closure suspects to primary angle closure: a population based study , 2003, The British journal of ophthalmology.

[21]  P. Alsbirk ANTERIOR CHAMBER DEPTH IN GREENLAND ESKIMOS , 1974, Acta ophthalmologica.

[22]  A. Fendrick,et al.  Suboptimal statin adherence and discontinuation in primary and secondary prevention populations , 2004, Journal of General Internal Medicine.

[23]  C. McCarty,et al.  Ocular biometry in occludable angles and angle closure glaucoma: a population based survey , 2003, The British journal of ophthalmology.

[24]  G. Johnson,et al.  The Burden of Trachoma in the Rural Nile Delta of Egypt : a Survey of Menofiya Governorate The Epidemiology of Ocular Trauma in Singapore : Perspective from the Emergency Service of a Large Tertiary Hospital , 2005 .

[25]  M. Nurminen,et al.  Incidence of acute glaucoma in Finland from 1973 to 1982 , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[26]  N. Congdon,et al.  Biometry and primary angle-closure glaucoma among Chinese, white, and black populations. , 1997, Ophthalmology.

[27]  J. Tsai,et al.  Current and emerging medical therapies for glaucoma , 2005, Expert opinion on emerging drugs.

[28]  J. Lai,et al.  Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study. , 2001, Hong Kong medical journal = Xianggang yi xue za zhi.

[29]  S. West,et al.  Prevalence of glaucoma in a rural East African population. , 2000, Investigative ophthalmology & visual science.

[30]  J. Pichert,et al.  Situational Obstacles to Adherence for Adolescents with Diabetes , 1994, The Diabetes educator.

[31]  G. Schwartz Compliance and persistency in glaucoma follow-up treatment , 2005, Current opinion in ophthalmology.

[32]  J. Avorn,et al.  Treatment for glaucoma: adherence by the elderly. , 1993, American journal of public health.

[33]  P. Foster,et al.  Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey. , 1997, Archives of ophthalmology.

[34]  P. Foster,et al.  Glaucoma in Mongolia. A population-based survey in Hövsgöl province, northern Mongolia. , 1996, Archives of ophthalmology.

[35]  F. Camacho,et al.  Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization. , 2003, The American journal of geriatric pharmacotherapy.

[36]  S. K. Seah,et al.  Anterior chamber depth and the risk of primary angle closure in 2 East Asian populations. , 2005, Archives of ophthalmology.

[37]  A. Iwase,et al.  The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. , 2005, Ophthalmology.

[38]  M. C. Leske,et al.  Prevalence of open-angle glaucoma among adults in the United States. , 2004, Archives of ophthalmology.

[39]  S. Strakowski,et al.  Factors associated with medication adherence in African American and white patients with bipolar disorder. , 2005, The Journal of clinical psychiatry.

[40]  Qian-Li Xue,et al.  Impaired Vision and the Ability to Take Medications , 2005, Journal of the American Geriatrics Society.

[41]  Wanzhu Tu,et al.  A conceptual framework to study medication adherence in older adults. , 2004, The American journal of geriatric pharmacotherapy.

[42]  Robert Michael Richards,et al.  Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes , 2004, The Annals of pharmacotherapy.

[43]  M. Lowe Primary Angle Closure Glaucoma: A Review of Ocular Biometry , 1977 .

[44]  A. Paes,et al.  Impact of Dosage Frequency on Patient Compliance , 1997, Diabetes Care.

[45]  J. Schouten,et al.  Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. , 2005, Ophthalmology.

[46]  D. Machin,et al.  The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. , 2000, Archives of ophthalmology.

[47]  P. Foster,et al.  The definition and classification of glaucoma in prevalence surveys , 2002, The British journal of ophthalmology.

[48]  J. Urquhart The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response. , 2002, British journal of clinical pharmacology.

[49]  R. Thomas,et al.  Prevalence of primary glaucoma in an urban south Indian population. , 1998, Indian journal of ophthalmology.

[50]  P. Hung,et al.  Biometric study of acute primary angle-closure glaucoma. , 1997, Journal of the Formosan Medical Association = Taiwan yi zhi.

[51]  J. Cramer,et al.  A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.

[52]  B. Guo,et al.  Primary chronic angle-closure glaucoma in Chinese--a clinical exploration of its pathogenesis and natural course. , 1994, Yan ke xue bao = Eye science.

[53]  N. Congdon,et al.  Screening techniques for angle-closure glaucoma in rural Taiwan. , 2009, Acta ophthalmologica Scandinavica.

[54]  N. Congdon,et al.  Age, gender, biometry, refractive error, and the anterior chamber angle among Alaskan Eskimos. , 2003, Ophthalmology.

[55]  T. Wagner,et al.  Patient Strategies to Cope with High Prescription Medication Costs: Who is Cutting Back on Necessities, Increasing Debt, or Underusing Medications? , 2005, Journal of Behavioral Medicine.

[56]  Eve A Kerr,et al.  The role of patient-physician trust in moderating medication nonadherence due to cost pressures. , 2005, Archives of internal medicine.

[57]  R. Lowe Causes of shallow anterior chamber in primary angle-closure glaucoma. Ultrasonic biometry of normal and angle-closure glaucoma eyes. , 1969, American journal of ophthalmology.

[58]  Joseph Thomas,et al.  Evaluation of an antiretroviral medication attitude scale and relationships between medication attitudes and medication nonadherence. , 2005, AIDS patient care and STDs.

[59]  P. Muntner,et al.  Methods to improve medication adherence in patients with hypertension: current status and future directions , 2005, Current opinion in cardiology.

[60]  S. Resnikoff,et al.  Global data on visual impairment in the year 2002. , 2004, Bulletin of the World Health Organization.

[61]  R. Kaplan,et al.  Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. , 2004, Preventive medicine.

[62]  H. Quigley Number of people with glaucoma worldwide. , 1996, The British journal of ophthalmology.

[63]  H A Quigley,et al.  THE NUMBER OF PERSONS WITH GLAUCOMA WORLDWIDE , 1996 .

[64]  F. Hollows,et al.  Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. , 1966, The British journal of ophthalmology.

[65]  P. Foster,et al.  Anterior chamber depth in Mongolians: variation with age, sex, and method of measurement. , 1997, American journal of ophthalmology.

[66]  G. Marchini,et al.  Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket Glaucoma Study. , 2000, Ophthalmology.

[67]  A R Feinstein,et al.  On white-coat effects and the electronic monitoring of compliance. , 1990, Archives of internal medicine.

[68]  R. Dobson,et al.  Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. , 2005, The Canadian journal of cardiology.

[69]  A. Rotchford,et al.  Glaucoma in Zulus: a population-based cross-sectional survey in a rural district in South Africa. , 2002, Archives of ophthalmology.

[70]  M. Ivanišević,et al.  The incidence and seasonal variations of acute primary angle-closure glaucoma. , 2002, Collegium antropologicum.

[71]  D G Schlundt,et al.  Situational obstacles to dietary adherence for adults with diabetes. , 1994, Journal of the American Dietetic Association.

[72]  Rajesh Balkrishnan,et al.  The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. , 2005, Medical care.

[73]  A. Mermoud,et al.  The prevalence of primary angle closure glaucoma and open angle glaucoma in Mamre, western Cape, South Africa. , 1993, Archives of ophthalmology.

[74]  J. Erie,et al.  The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota. , 1997, Archives of ophthalmology.

[75]  Scott R. Smith,et al.  Factors Influencing Medication Adherence Beliefs and Self-Efficacy in Persons Naive to Antiretroviral Therapy: A Multicenter, Cross-Sectional Study , 2004, AIDS and Behavior.

[76]  S. Tsukahara,et al.  Epidemiology of glaucoma in Japan--a nationwide glaucoma survey. , 1991, Japanese journal of ophthalmology.

[77]  J. Zhao [An epidemiological survey of primary angle-closure glaucoma (PACG) in Tibet]. , 1990, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[78]  T. Wagner,et al.  Cost-related medication underuse: do patients with chronic illnesses tell their doctors? , 2004, Archives of internal medicine.

[79]  D. Morrow,et al.  Patient-centered instructions for medications prescribed for the treatment of heart failure. , 2004, The American journal of geriatric pharmacotherapy.

[80]  J. Pichert,et al.  Compliance Barriers in Glaucoma: A Systematic Classification , 2003, Journal of glaucoma.

[81]  L. Cavalli-Sforza Genes, peoples and languages. , 1991, Scientific American.

[82]  Ravi Thomas,et al.  Five-year risk of progression of primary angle closure to primary angle closure glaucoma: a population-based study. , 2003, Acta ophthalmologica Scandinavica.

[83]  J Urquhart,et al.  The Electronic Medication Event Monitor , 1997, Clinical pharmacokinetics.

[84]  J. Cramer,et al.  Compliance declines between clinic visits. , 1990, Archives of internal medicine.

[85]  P. Alsbirk Primary angle-closure glaucoma. Oculometry, epidemiology, and genetics in a high risk population. , 1976, Acta ophthalmologica. Supplementum.

[86]  B. Meyers,et al.  Effects of caregivers' perceived stigma and causal beliefs on patients' adherence to antidepressant treatment. , 2005, Psychiatric services.

[87]  N. Congdon,et al.  Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. , 1992, Survey of ophthalmology.

[88]  R. Bhopal Is research into ethnicity and health racist, unsound, or important science? , 1997, BMJ.

[89]  H. Taylor,et al.  The prevalence of glaucoma in the Melbourne Visual Impairment Project. , 1998, Ophthalmology.

[90]  P. Foster,et al.  Biometric gonioscopy and the effects of age, race, and sex on the anterior chamber angle , 2002, The British journal of ophthalmology.

[91]  A. Rotchford,et al.  Compliance with timolol treatment in glaucoma , 1998, Eye.

[92]  J. Jackson,et al.  Perceived versus actual medication regimens among internal medicine patients. , 2004, Military medicine.

[93]  Catherine Pope,et al.  Resisting medicines: a synthesis of qualitative studies of medicine taking. , 2005, Social science & medicine.

[94]  A. Tomlinson,et al.  Ocular dimensions in the heredity of angle-closure glaucoma. , 1973, The British journal of ophthalmology.

[95]  A. Moscicki,et al.  Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. , 2003, Archives of pediatrics & adolescent medicine.